Mesa Laboratories (MLAB) Liabilities and Shareholders Equity (2011 - 2025)

Mesa Laboratories (MLAB) has 15 years of Liabilities and Shareholders Equity data on file, last reported at $434.8 million in Q4 2025.

• Quarterly Liabilities and Shareholders Equity changed 0.35% year-over-year to $434.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.7 billion (down 2.27% YoY) and the FY2025 annual result came in at $433.3 million, down 3.01% from the prior year.
• Liabilities and Shareholders Equity advanced to $434.8 million in Q4 2025 per MLAB's latest filing, from $430.4 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $741.8 million in Q4 2023, with the low at $430.4 million in Q3 2025.
• Average Liabilities and Shareholders Equity over 5 years is $572.5 million, with a median of $610.8 million recorded in 2021.
• Year-over-year, Liabilities and Shareholders Equity soared 47.02% in 2021 and plunged 41.58% in 2024.
• Mesa Laboratories' Liabilities and Shareholders Equity stood at $721.7 million in 2021, then fell by 8.14% to $663.0 million in 2022, then advanced by 11.88% to $741.8 million in 2023, then sank by 41.58% to $433.3 million in 2024, then gained by 0.35% to $434.8 million in 2025.
• Business Quant data shows MLAB's Liabilities and Shareholders Equity at $434.8 million in Q4 2025, $430.4 million in Q3 2025, and $435.7 million in Q2 2025.